Nathan Michael Bass
#165,020
Most Influential Person Now
Nathan Michael Bass's AcademicInfluence.com Rankings
Nathan Michael Bassmedical Degrees
Medical
#3380
World Rank
#3848
Historical Rank
Gastroenterology
#85
World Rank
#88
Historical Rank
Epidemiology
#645
World Rank
#671
Historical Rank
Nathan Michael Bassphilosophy Degrees
Philosophy
#9675
World Rank
#13267
Historical Rank
Logic
#6644
World Rank
#8178
Historical Rank
Download Badge
Medical Philosophy
Nathan Michael Bass's Degrees
- Bachelors Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
- Masters Epidemiology University of California, Berkeley
Why Is Nathan Michael Bass Influential?
(Suggest an Edit or Addition)Nathan Michael Bass's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010) (2333)
- Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival (2001) (1973)
- SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. (2011) (671)
- Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. (1987) (660)
- Rifaximin treatment in hepatic encephalopathy. (2010) (536)
- Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis (2008) (501)
- Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging (2007) (481)
- Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease (2010) (420)
- Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria (2002) (397)
- Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis (2012) (390)
- Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention‐to‐treat principle and dropout from the waiting list (2002) (389)
- Serum sodium predicts mortality in patients listed for liver transplantation (2005) (380)
- Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease (2005) (358)
- Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease (2006) (311)
- Interactions of flurochemicals with rat liver fatty acid-binding protein (2002) (299)
- Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort (2001) (277)
- A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation (2005) (274)
- Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy (2005) (262)
- A follow‐up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy (2003) (259)
- The cellular fatty acid binding proteins: aspects of structure, regulation, and function. (1988) (258)
- Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure (1992) (228)
- Magnetic resonance imaging and spectroscopy of hepatic iron overload. (1985) (209)
- A model to predict severe HCV‐related disease following liver transplantation (2003) (200)
- Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. (2000) (187)
- Ethnicity and nonalcoholic fatty liver disease (2012) (184)
- Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay (2008) (179)
- Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. (2014) (179)
- Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. (1985) (177)
- Function and regulation of hepatic and intestinal fatty acid binding proteins. (1985) (170)
- The Impact of Pre‐Operative Loco‐Regional Therapy on Outcome After Liver Transplantation for Hepatocellular Carcinoma (2005) (168)
- A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients (2008) (164)
- Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. (1997) (154)
- Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function (1995) (153)
- Cloning of a cDNA encoding rat intestinal fatty acid binding protein. (1984) (151)
- Health‐related fitness and physical activity in patients with nonalcoholic fatty liver disease (2008) (149)
- A Randomized Trial of Exercise and Dietary Counseling After Liver Transplantation (2006) (146)
- New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection (2004) (141)
- Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy (2014) (135)
- Nuclear magnetic resonance imaging of experimentally induced liver disease. (1983) (134)
- Long‐term follow‐up of portopulmonary hypertension: Effect of treatment with epoprostenol (2007) (130)
- Interactions of fluorochemicals with rat liver fatty acid-binding protein. (2002) (127)
- Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors (2010) (121)
- Fatty‐acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis (1993) (119)
- Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease (2017) (119)
- Randomised clinical trial: rifaximin improves health‐related quality of life in cirrhotic patients with hepatic encephalopathy – a double‐blind placebo‐controlled study (2011) (116)
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. (2019) (114)
- Light microscopic immunocytochemical localization of hepatic and intestinal types of fatty acid-binding proteins in rat small intestine. (1986) (114)
- Chronic liver disease: evaluation by magnetic resonance. (1984) (114)
- Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis (2005) (113)
- Ligandin heterogeneity : evidence that the two non-identical subunits are the monomers of two distinct proteins. (1977) (113)
- Tissue expression of three structurally different fatty acid binding proteins from rat heart muscle, liver, and intestine. (1986) (112)
- The immunobiology of bile and biliary epithelium (1999) (111)
- Fetal epidermal differentiation and barrier development In vivo is accelerated by nuclear hormone receptor activators. (1999) (104)
- Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. (2005) (103)
- Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. (2008) (103)
- Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores (2004) (103)
- Induction of peroxisomal fatty acid beta-oxidation and liver fatty acid-binding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVA1 omega-hydroxylase pathway. (1993) (101)
- Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End‐Stage Liver Disease (MELD) organ allocation policy (2004) (101)
- Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. (2005) (100)
- Sterol carrier protein 2 and fatty acid-binding protein. Separate and distinct physiological functions. (1985) (97)
- Long‐term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation database (2004) (92)
- Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-α (PPARα)-Regulated Genes and Is Ameliorated by PPARα Activation (2004) (91)
- Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow‐up study (2012) (90)
- Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. (1976) (87)
- Objective measures of health‐related quality of life over 24 months post‐liver transplantation (2005) (85)
- Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis (2014) (83)
- Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group. (2000) (82)
- Functions of fatty acid binding proteins (1990) (81)
- Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. (2005) (81)
- Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. (2009) (80)
- Survival after liver transplantation in patients with hepatic iron overload (2005) (78)
- Review article: the current pharmacological therapies for hepatic encephalopathy (2007) (77)
- Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis (2000) (77)
- Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation. (1990) (76)
- Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease. (2006) (75)
- Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. (1994) (69)
- Lack of efficacy of TIPS for hepatopulmonary syndrome. (1997) (69)
- Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation (2010) (65)
- Training the gastroenterologist of the future: the Gastroenterology Core Curriculum. (2003) (64)
- Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine. (2000) (64)
- SIRT 3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic Syndrome (2011) (62)
- Vanishing bile duct syndrome temporally associated with ibuprofen use. (1996) (61)
- Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality (2018) (61)
- Radioimmunoassay of plasma ligandin: a sensitive index of experimental hepatocellular necrosis. (1978) (60)
- Transfer of fluorescent fatty acids from liver and heart fatty acid-binding proteins to model membranes. (1990) (60)
- Partial purification of molecular weight 12 000 fatty acid binding proteins from rat brain and their effect on synaptosomal Na+-dependent amino acid uptake. (1984) (58)
- Chronic intrahepatic cholestasis due to sarcoidosis. (1982) (58)
- Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. (2008) (57)
- Genetic influences in nonalcoholic fatty liver disease. (2006) (57)
- Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites (2000) (57)
- Evidence for a novel keratinocyte fatty acid uptake mechanism with preference for linoleic acid: comparison of oleic and linoleic acid uptake by cultured human keratinocytes, fibroblasts and a human hepatoma cell line. (1994) (56)
- Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I. (1993) (55)
- Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate‐treated rats (1989) (55)
- Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. (2004) (55)
- Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis (2011) (54)
- Diffuse Intrahepatic Biliary Strictures in Sarcoidosis Resembling Sclerosing Cholangitis (Case Report and Review of the Literature) (1997) (53)
- Guide to Drug Dosage in Hepatic Disease (1988) (52)
- Isolation and characterization of fatty acid binding proteins from mammary tissue of lactating rats. (1988) (51)
- The primary structure of fatty-acid-binding protein from nurse shark liver. Structural and evolutionary relationship to the mammalian fatty-acid-binding protein family. (1992) (51)
- Studies of the fatty acid-binding site of rat liver fatty acid-binding protein using fluorescent fatty acids. (1989) (51)
- High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome (2005) (50)
- Immunohistological localization of ligandin in human tissues (1980) (49)
- An algorithm for the management of hepatic encephalopathy (2007) (48)
- Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. (1999) (46)
- Long-standing asymptomatic primary sclerosing cholangitis report of three cases (1981) (43)
- Mechanisms of regulation of liver fatty acid-binding protein (1993) (41)
- Mechanism‐based probes of the topology and function of fatty acid hydroxylases (1992) (40)
- Turnover and short-term regulation of fatty acid binding protein in liver. (1985) (40)
- Medical treatment of non-alcoholic steatohepatitis. (2007) (40)
- Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus (2011) (38)
- Radioimmunoassay of Human Ligandin (2007) (37)
- Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC (1999) (37)
- Severe Hyperbilirubinemia after Creation of Transjugular Intrahepatic Portosystemic Shunts: Natural History and Predictors of Outcome (1998) (36)
- Radioimmunoassay of ligandin. (1977) (34)
- Lipidomic dissection of nonalcoholic steatohepatitis: Moving beyond foie gras to fat traffic (2010) (32)
- Autonomic nervous system tone measured by baroreflex sensitivity is depressed in patients with end-stage liver disease (1999) (31)
- Fatty Acid Binding Proteins in the Three Types of Rat Skeletal Muscle (1988) (30)
- Cellular binding proteins for fatty acids and retinoids: similar or specialized functions? (1993) (30)
- Emergent Orthotopic Liver Transplantation for Hemorrhage from a Giant Cavernous Hepatic Hemangioma: Case Report and Review (2010) (30)
- Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety. (2005) (28)
- Left atrial myxoma diagnosed by echocardiography, with observations on tumour movement. (1973) (28)
- Fatty acid-binding protein expression in the liver: its regulation and relationship to the zonation of fatty acid metabolism (2004) (27)
- Results of Early Mobilization and Discharge after Myocardial Infarction (1973) (27)
- Fatty acid binding sites of rodent adipocyte and heart fatty acid binding proteins: characterization using fluorescent fatty acids. (1990) (26)
- Nuclear magnetic resonance imaging of experimentally induced liver disease (1984) (26)
- Is there any use for nontraditional or alternative therapies in patients with chronic liver disease? (1999) (24)
- A methylsulfonyl metabolite of a polychlorinated biphenyl can serve as a ligand for liver fatty acid binding protein in rat intestinal mucosa. (1991) (23)
- HEPATIC GRANULOMAS FOLLOWING LIVER TRANSPLANTATION CLINICOPATHOLOGIC FEATURES IN 42 PATIENTS (1995) (23)
- In situ binding of fatty acids to the liver fatty acid binding protein: analysis using 3-[125I]iodo-4-azido-N-hexadecylsalicylamide. (1991) (22)
- CT signs of hepatofugal portal venous flow in patients with cirrhosis. (2003) (21)
- Association between cytokines and liver histology in children with nonalcoholic fatty liver disease (2017) (21)
- Revision of the blocked N terminus of rat heart fatty acid-binding protein by liquid secondary ion mass spectrometry. (1988) (20)
- CASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure (2000) (20)
- Hepatic transport of a fluorescent stearate derivative: electrochemical driving forces in intact rat liver. (1991) (19)
- Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. (1992) (19)
- Influence of genetic obesity and of fat-feeding on hepatic FABP concentration and activity. (1988) (19)
- Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis. (1999) (19)
- Radioimmunoassay measurement of urinary ligandin excretion in nephrotoxin-treated rats. (1979) (19)
- Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma (1998) (19)
- Curricular guidelines for training in transplant hepatology (2002) (18)
- Lipopeliosis. An immunohistochemical and clinicopathologic study of five cases. (1994) (18)
- Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary (2016) (17)
- Primary sclerosing cholangitis associated with angioimmunoblastic lymphadenopathy (1983) (17)
- Radioimmunoassay of Plasma Ligandin: A sensitive index of experimental hepatocellular necrosis (1978) (16)
- Testosterone is Associated With Nonalcoholic Steatohepatitis (NASH) and Fibrosis in Pre-Menopausal Women With NAFLD. (2020) (15)
- Monitoring and treatment of intracranial hypertension (2000) (15)
- Randomised, controlled study of transhepatic obliteration of varices and oesophageal stapling transection in uncontrolled variceal haemorrhage. (2008) (15)
- Expression of fatty acid binding protein in the liver during pregnancy and lactation in the rat. (1995) (14)
- Treatment of hepatorenal syndrome with the transjugular intrahepatic portosystemic shunt (TIPS) (1995) (14)
- Hepatic granulomas following liver transplantation : clinicopathologic features in 42 patients (1995) (14)
- 158 Histologic correlation of paired right lobe and left lobe liver biopsies in morbidly obese individuals with suspected non alcoholic fatty liver disease (2003) (14)
- A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH (2019) (13)
- 195 RIFAXIMIN DECREASES VENOUS AMMONIA CONCENTRATIONS AND TIME-WEIGHTED AVERAGE AMMONIA CONCENTRATIONS CORRELATE WITH OVERT HEPATIC ENCEPHALOPATHY (HE) AS ASSESSED BY CONN SCORE IN A 6-MONTH STUDY (2010) (13)
- Three for the price of one knockout—a mouse model of a congenital peroxisomal disorder, steatohepatitis, and Hepatocarcinogenesis (1999) (13)
- 93 RIFAXIMIN IS EFFECTIVE IN MAINTAINING REMISSION IN HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (2009) (12)
- Metabolism of 15-hydroxyeicosatetraenoic acid by Caco-2 cells. (1990) (12)
- Fatty Acid Metabolism and Lipotoxicity in the Pathogenesis of NAFLD/NASH (2007) (12)
- Immunological identity of rat liver cytosolic heme-binding protein with purified and recombinant liver fatty acid binding protein by western blots of two-dimensional gels. (1994) (12)
- Transplant tourism to China: the impact on domestic patient‐care decisions (2009) (12)
- The treatment of hepatic encephalopathy in the cirrhotic patient. (2010) (11)
- 7 Efficacy and tolerability of preemptive interferon (IFN) versus IFN plus ribavirin (RBV) treatment in hepatitis C virus (HCV) infected liver transplant recipients (2003) (11)
- Fatty acid binding proteins: recent concepts of regulation and function. (1992) (11)
- Increased sinusoidal volume and solute extraction during retrograde liver perfusion. (1989) (11)
- 3 The impact of expansion of conventional tumor criteria and pre-operative loco-regional treatments on survival following liver transplantation for hepatocellular carcinoma: results from two centers (2003) (11)
- Isolation and characterization of fatty acid binding protein in the liver of the nurse shark, Ginglymostoma cirratum. (1991) (11)
- Echocardiography in assessment of infants with complete d-transposition of great arteries. (1978) (10)
- 15 RIFAXIMIN TREATMENT IMPROVED QUALITY OF LIFE IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (2010) (10)
- Ligandin concentrations in the steroidogenic tissues of the rat during development. (1984) (10)
- The role of the interventional radiologist. Transjugular procedures. (2001) (9)
- High-affinity fatty acid-binding activity in epidermis and cultured keratinocytes is attributable to high-molecular-weight and not low-molecular-weight fatty acid-binding proteins. (1993) (9)
- Endovascular closure of a portocaval shunt after left lobe liver transplantation using an amplatzer muscular ventricular septal occluder device (2011) (8)
- Subdural empyema after endoscopic sclerotherapy. (1989) (8)
- Preventing hemorrhage from esophageal varices. (1987) (7)
- Emerging Therapies for the Management of Hepatic Encephalopathy (2007) (7)
- Primary sclerosing cholangitis. (2003) (7)
- Primary biliary cirrhosis: from induction to destruction. (2001) (7)
- alpha-Fetoprotein in liver disease. (1978) (7)
- 645 RATES OF COMMONLY OCCURING INFECTIONS IN CIRRHOSIS PATIENTS REMAIN STABLE DURING LONG-TERM RIFAXIMIN TREATMENT (2012) (6)
- Absence of splenic uptake of radiocolloid due to Thorotrast in a patient with Thorotrast-induced cholangiocarcinoma. (1982) (6)
- Organization and zonation of hepatic lipid metabolism (1989) (6)
- 806 The effect of recombinant factor VIIA and fresh frozen plasma on the INR in patients with acute and chronic liver failure (2003) (6)
- 207 SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL (2009) (5)
- 222 CHRONIC ADMINISTRATION OF RIFAXIMIN FOR THE MAINTENANCE OF REMISSION OF HEPATIC ENCEPHALOPATHY: A SUBGROUP ANALYSIS OF A PHASE 3 TRIAL (2009) (4)
- Safety and efficacy of TIPS in patients with hemophilia and cirrhosis. (2007) (4)
- Modest expansion of the tumor size limits does not adversely impact survival following liver transplantation for hepatocellular carcinoma: Proposal of a new staging criterion (2001) (4)
- Task force on training in research (1996) (4)
- It could have been something they ate -- functional food and the treatment of liver cancer. (2002) (4)
- Amyloidosis localized to the liver. (2007) (3)
- Leukotriene antagonists. (2003) (3)
- QUANTITATION AND CHARACTERIZATION OF FATTY ACID BINDING PROTEIN IN 3 MUSCLE FIBER TYPES OF RAT HINDL IMB (1986) (3)
- Role of TIPS in portal hypertension: variceal bleeding and ascites (1998) (3)
- 168 The Long Term Efficacy and Safety of Rifaximin in the Maintenance of Remission From Overt Hepatic Encephalopathy in Cirrhotic Patients (2012) (3)
- Isolation of Pesticide-Binding Protein from Rat Blood (1993) (3)
- Serum fibrosis markers predict future clinical decompensation in primary biliary cirrhosis better than liver biopsy, bilirubin, or Mayo Risk score (2006) (3)
- Interaction of Lipid-Lowering Drugs with Fatty Acid-Binding Proteins (1987) (2)
- Health-Related Fitness and Physical Activity Participation Among Individuals with Non-Alcoholic Fatty Liver Disease: 2400 (2007) (2)
- Post-transplantation (LT) significant HCV-related disease severity: Increase in recent years (2000) (2)
- Potential reduction of post-transplantation HCV-related disease progression by a better selection of the donor (2002) (2)
- ASSESSMENT OF EXPERIMENTALLY INDUCED LIVER DISEASE BY NMR IMAGING (1983) (2)
- Emerging Issues in Gastroenterology and Hepatology (2009) (2)
- Interaction of Fatty Acid-Binding Proteins with the Peroxisome Proliferator-Activated Receptor Alpha (1996) (1)
- Rifaximin has a Favorable Long-Term Safety Profile for Maintenance of Remission from Overt Hepatic Encephalopathy: 360 (2009) (1)
- 725 Variants of adipocyte genes affecting free fatty acid flux in patients with non alcoholic fatty liver disease (2003) (1)
- The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver (1989) (1)
- Hepatic tumors and pregnancy (1991) (1)
- Alanine Aminotransferase (ALT) Elevation in Obese Children and Adolescents: A Predictor of Insulin Resistance and Possible Precursor to Metabolic Syndrome (2011) (1)
- From treatment planning to treatment results: The luck of the draw? (2001) (1)
- Book Review Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment Second edition. Edited by Pere Ginès, Vicente Arroyo, Juan Rodés, and Robert W. Schrier. 450 pp., illustrated. Malden, Mass., Blackwell, 2005. $174.95. 1-405-11804-0 (2006) (1)
- Abnormal liver function tests in the patient transplanted 3 years ago for alcoholic liver disease (2006) (1)
- A variant of the microsomal triglyceride transfer protein gene in patients with non-alcoholic steatohepatitis (2003) (1)
- Dietary fat composition influences cell injury in experimental alcoholic liver disease and has divergent effects on the expression of liver fatty acid binding protein , and enzymes of extramitochondrial fatty acid oxidation (1996) (1)
- Liver transplantation for hepatocellular carcinoma: The impact of pre-operative chemoembolization and ablation (2003) (1)
- Atlas of the Liver, 4th ed. Mark Feldman (Series Editor) and Willis Maddrey (Editor-in-Chief). CD ROM. $99.00. Philadelphia, Pennsylvania, Current Medicine Group, LLC. ISBN 1-57340-262-1. Website for ordering:www.current-medicine.com/ordering.cfm (2008) (0)
- Reply: (2012) (0)
- Phosphorus imaging of brain in hepatic encephalopathy (1989) (0)
- Book reviewHepatobiliary diseasesHepatobiliary diseases. Edited by Jesús Prieto, Joan Rodés, and David A. Shafritz. 1128 pp. $150.00. Springer-Verlag, New York, Berlin, Heidelberg, 1992. ISBN 0-387-54326-0 (1993) (0)
- Coronary artery disease in NASH-related cirrhosis (2009) (0)
- In memoriam: Robert K. Ockner, MD. (2023) (0)
- 433 Liver transplantation for hepatocellular carcinoma before and after the MELD system for organ allocation: a prospective analysis using an intention to treat principle (2003) (0)
- In Memoriam: Robert K. Ockner, MD. (2022) (0)
- The presence of mitochondrial autoantModies in saliva in primary biliary cirrhosis - evidence for a locally driven mucosal response (2000) (0)
- Non-alcoholic fatty liver disease is common in morbidly obese individuals with normal aminotransferases (2003) (0)
- PerOXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐α‐MEDIATED GENE EXPRESSION AND ADAPTATION TO FATTY ACID OVERLOAD IN ALCOHOLIC LIVER DISEASE (1998) (0)
- NOT TRANSPLANTING IS AN EXPENSIVE PROPOSITION.: Abstract# 759 Poster Board #‐Session: P16‐III (2000) (0)
- HEPATITIS C VIRUS (HCV) IS ASSOCIATED WITH NEW ONSET DIABETES MELLITUS (DM) AFTER LIVER TRANSPLANTATION (OLT): IMPACT ON PATIENT AND GRAFT SURVIVAL (1999) (0)
- Comment on soft tissue profile. (1996) (0)
- Family History of Diabetes and Risk of Nonalcoholic Steatohepatitis and Hepatic Fibrosis (2011) (0)
- Endoscopic management of primary sclerosing cholangitis (PSC) results in slowing of disease progression (2000) (0)
- Encephalopathy and nitrogen metabolism in liver failure: edited by E. Anthony Jones, Alfred J. Meier, and Robert A.F.M. Chamuleau. 452 pp. $193.00. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2003. ISBN 1-4020-1157-1. Web address for ordering: www.wkap.nl (2004) (0)
- Continuous epoprostenol (prostacyclin) infusion improves both portopulmonary hypertension and hepatic function (2001) (0)
- A Brief History of Hepatic Encephalopathy (2021) (0)
- Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator- (cid:1) (PPAR (cid:1) )-Regulated Genes and Is Ameliorated by PPAR (cid:1) Activation (2004) (0)
- blockers in the management of portal hypertension (1988) (0)
- Acute severe presentation of autoimmune hepatitis: a 20-year retrospective review of the United States (2022) (0)
- Hepatobiliary diseases: Edited by Jesús Prieto, Joan Rodés, and David A. Shafritz. 1128 pp. $150.00. Springer-Verlag, New York, Berlin, Heidelberg, 1992. ISBN 0-387-54326-0 (1993) (0)
- Cloning of a cDNA encoding rat intestinal-fatty acid binding protein ( cDNA cloning / primary and secondary protein structure analyses ) (0)
- Long Term Prospective Follow-Up of Aggressive Endoscopic Therapy in Patients with Primary Sclerosing Cholangitis (2005) (0)
- The role of glutathione S‐transferases in the metabolism of xenobiotics (1988) (0)
- Ockner In Memoriam (2022) (0)
- Symptoms of Sjögrenʼs Syndrome in Patients with Primary Biliary Cirrhosis Improve after Liver Transplantation: 321 (2005) (0)
- Process for treating the epidermis or mucous membrane of a mammalian subject. (1998) (0)
- Regenerative nodules in acute or subacute hepatic failure mimic multifocal hepatocellular carcinoma (HCC) on computerized tomographic imaging (CT) (2000) (0)
- P1070 FAILURE TO DIAGNOSE OBESITY AND SCREEN FOR FATTY LIVER DISEASE IN PEDIATRIC PRACTICE (2004) (0)
- with acquired coagulopathy of liver disease Photochemically treated fresh frozen plasma for transfusion of patients (2012) (0)
- 154: Pre-lung transplant immunosuppression assessment of candidates with risk of possible hepatitis C (HCV) post-transplantation (2007) (0)
- Glutathione S‐transferases: Of rats and men (1986) (0)
- Reply: (2008) (0)
- Autoimmune hepatitis presenting as acute liver failure. A 20-year retrospective review of North America. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nathan Michael Bass?
Nathan Michael Bass is affiliated with the following schools:
